4//SEC Filing
Auspex Pharmaceuticals, Inc. 4
Accession 0001209191-15-039540
CIK 0001454189operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 6:03 PM ET
Size
6.0 KB
Accession
0001209191-15-039540
Insider Transaction Report
Form 4
Zisson Alex
Director10% Owner
Transactions
- Disposition from Tender
Common Stock
2015-05-05−4,835,731→ 0 total(indirect: See footnote)
Footnotes (3)
- [F1]Includes 4,768,041 shares held in the name of Thomas, McNerney & Partners II, L.P. ("TMP II"); 49,805 shares held in the name of TMP Nominee II, LLC ("TMPN II"); and 17,885 shares held in the name of Associates II, L.P. ("TMPA II").
- [F2]Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated March 29, 2015, among the Issuer, Teva Pharmaceuticals Industries Ltd. ("Parent"), and Aurum Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub") in exchange for a cash consideration of $101.00 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation.
- [F3]The securities are held in the name of TMP II, TMPN II and TMPA II. Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II. Alex Zisson is a manager of TMP II LLC and has shared voting and dispositive power over the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Auspex Pharmaceuticals, Inc.
CIK 0001454189
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454189
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 6:03 PM ET
- Size
- 6.0 KB